HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Paediatric Acute Respiratory Illness (ARI) encompasses a spectrum of respiratory disorders affecting infants, children, and adolescents, presenting a complex and multifaceted clinical challenge. Defined by a sudden onset of respiratory symptoms, ARI includes conditions such as bronchiolitis, pneumonia, croup, and influenza, among others. The respiratory system of Paediatric patients is particularly vulnerable, as their airways are smaller and more susceptible to obstruction, making them prone to rapid deterioration. The etiology of Paediatric ARI is diverse, ranging from viral and bacterial infections to environmental factors, placing a significant burden on healthcare systems globally. Clinically, affected children often exhibit symptoms such as cough, wheezing, shortness of breath, and respiratory distress, necessitating timely and accurate diagnosis. Management strategies involve a combination of supportive care, oxygen therapy, and, in severe cases, mechanical ventilation. Prevention, primarily through vaccination against common respiratory viruses, plays a crucial role in reducing the incidence and severity of these illnesses. Despite advancements in medical care, Paediatric ARI remains a leading cause of morbidity and mortality worldwide, underscoring the importance of ongoing research, public health initiatives, and clinical interventions to improve outcomes for this vulnerable population. A comprehensive and integrated approach involving healthcare providers, caregivers, and public health efforts is essential to address the multifaceted challenges posed by Paediatric ARI and to ensure the well-being of children facing respiratory distress.
